HIV/AIDS Clinical Trials

Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00517569

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Condition: Human Immunodeficiency Virus

NCT ID: NCT01734850

Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r

Condition: HIV Infections

NCT ID: NCT00476502

Trial of an Anti-HIV-1 Gene Transfer Product

Condition: HIV-1

NCT ID: NCT00074997

Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000917

Terminated(En español)

Genotype Based Personalized Prescription of Nevirapine

Condition: Nevirapine Induced Rash; Nevirapine Induced Hepatitis; HIV; Adverse Side Effects; AIDS; HIV Infections

NCT ID: NCT00986063

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Condition: HIV Infection

NCT ID: NCT00131560

Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens

Condition: Alcoholism; HIV Infection; Homosexuality; Kaposi's Sarcoma

NCT ID: NCT00001294

Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer

Condition: Hematologic Neoplasm; HIV Infection

NCT ID: NCT00005785

Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV

Condition: HIV; HIV Infections

NCT ID: NCT00842634

Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy

Condition: HIV

NCT ID: NCT01787994

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Condition: Acquired Immunodeficiency Syndrome; HIV Infection

NCT ID: NCT00001353

Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00630734

Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits

Condition: Acquired Immunodeficiency Syndrome; Alcoholism; HIV Infection; Neoplasm; Smoking

NCT ID: NCT00001500

Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy

Condition: HIV Infections

NCT ID: NCT00991224

Genetic Markers for Focal Segmental Glomerulosclerosis

Condition: AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections

NCT ID: NCT00001393

Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity

Condition: HIV Infection

NCT ID: NCT00340080

Open Label Study to Evaluate the Safety, Efficacy, Viral Kinetics, Genetic, Epigenetic, and Proteomic Expression of Weekly Peginterferon Alpha 2a and Ribavirin Therapy for Chronic Hepatitis C in Latino Subjects With and Without HIV Co-infection

Condition: Hepatitis C; HIV

NCT ID: NCT01182298

Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

Condition: HIV Infection

NCT ID: NCT00009256

Active, not recruiting(En español)

Collection of Blood Samples From HIV Infected People

Condition: HIV Infections

NCT ID: NCT00096772

Case-Control Viramune (Nevirapine) Toxicogenomics Study

Condition: HIV Infections

NCT ID: NCT00310843

Microparticles, Vector of Genetic Information During HIV Infection

Condition: HIV,

NCT ID: NCT01687452

Analysis of Genetic Factors Which May Influence the Course of HIV Infection

Condition: HIV Infection

NCT ID: NCT00159068

Genetics and HIV-1 Protease Inhibitors

Condition: HIV

NCT ID: NCT01388543

Preference of Genetic Polymorphism and Pharmacokinetics

Condition: HIV

NCT ID: NCT01658371

Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid

Condition: HIV Infections

NCT ID: NCT00729924

Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors

Condition: HIV Infections

NCT ID: NCT00730223

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

Condition: HIV Infection

NCT ID: NCT00107029

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Condition: Hemophilia

NCT ID: NCT00340548

A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701

Condition: HIV Infection

NCT ID: NCT00435838

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Condition: HIV Infection; Hepatitis B

NCT ID: NCT00142740

the " Extreme " Cohort (CODEX)

Condition: HIV Infection

NCT ID: NCT01520844

Active, not recruiting(En español)

Collection of Blood Samples From SMART Study Participants for Future Genetic Studies

Condition: HIV Infections

NCT ID: NCT00377169

Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers

Condition: Healthy; HIV Infection

NCT ID: NCT00027482

Bangkok Tenofovir Study

Condition: HIV Infections

NCT ID: NCT00119106

Accelerated Aging, HIV Infection, Antiretroviral Therapies

Condition: HIV Infection; Aging Accelerated; Antiretroviral Therapies

NCT ID: NCT01038999

Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons

Condition: HIV Infection

NCT ID: NCT00001281

HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers

Condition: Healthy; HIV Infections

NCT ID: NCT00102089

Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)

Condition: HIV Infections

NCT ID: NCT01138267

Consent for Use of Stored Patient Specimens for Future Testing

Condition: HIV Infections

NCT ID: NCT00031408

Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00346476

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Condition: Anal Cancer; Cervical Cancer; Lung Cancer; Lymphoma; Nonneoplastic Condition

NCT ID: NCT01567722

Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome

Condition: PML; AIDS

NCT ID: NCT00342602

Age-17 Follow-up of Home Visiting Intervention

Condition: Antisocial Behavior; Psychopathology; Substance Use; HIV Infections

NCT ID: NCT00708695

Enrolling by invitation

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00453440

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

Condition: HIV Infections

NCT ID: NCT00029445

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

Condition: Hepatitis B; HIV Infection

NCT ID: NCT00013702

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Condition: HIV

NCT ID: NCT01423812

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Condition: Healthy; HIV Seronegativity

NCT ID: NCT00009685

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Condition: Tuberculosis; HIV

NCT ID: NCT01687504

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

Condition: Acquired Immunodeficiency Syndrome; Kaposi's Sarcoma; Leukemia; Lymphoma; Tumor Virus Infection; HIV Infections

NCT ID: NCT00001560

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00003942

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

Condition: AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Primary Central Nervous System Non-Hodgkin Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00003970

A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00000868

A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00004579

Acute HIV Infection Observational Study

Condition: HIV Infections

NCT ID: NCT00296660

A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00001136

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Condition: HIV Infections

NCT ID: NCT00000904

A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00000884

Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load

Condition: HIV Infections

NCT ID: NCT00013663

Analysis of HIV-1 Replication During Antiretroviral Therapy

Condition: HIV Infection

NCT ID: NCT00767312

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Condition: Healthy

NCT ID: NCT00045838

Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients

Condition: Immune Reconstitution Inflammatory Syndrome; HIV; HIV Infections

NCT ID: NCT00988780

HIV Diversity and Pathogenesis in Donor-Recipient Clusters

Condition: Acquired Immunodeficiency Syndrome; Blood Transfusion; Blood Donors; HIV Infections

NCT ID: NCT00005360

Predictors of Drug Hypersensitivity in HIV Infected Subjects

Condition: HIV Infections; Hypersensitivity

NCT ID: NCT00168220

Cerebral Toxoplasmosis and AIDS

Condition: Cerebral Toxoplasmosis; AIDS

NCT ID: NCT00803621

Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002415

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Condition: Lymphoma

NCT ID: NCT00569985

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00006298

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

Condition: HIV Infection

NCT ID: NCT00131677

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00051090

Withdrawn(En español)

Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00802802

Examining Factors That May Influence Resistance to HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00351442

Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents

Condition: HIV Infection

NCT ID: NCT01492803

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00207948

Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression

Condition: HIV Infections

NCT ID: NCT00125814

A Comparison of Two Tests for Anti-HIV Drug Resistance

Condition: HIV Infections

NCT ID: NCT00006490

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

Condition: HIV Infections; Meningitis

NCT ID: NCT00459316

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00849160

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients

Condition: HIV-1 Infection

NCT ID: NCT01019551

Comparison of the QT/QTc Intervals Between an Outpatient HIV Positive Population on Antiretroviral Therapy and an Outpatient HIV Negative Population

Condition: QT and Corrected QT Intervals Prolongation in HIV Positive Subjects Treated With an Antiretroviral Regimen

NCT ID: NCT01824628

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Condition: HIV Infections

NCT ID: NCT00000984

Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

Condition: HIV Infections

NCT ID: NCT01047995

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

Condition: Hepatitis B; HIV Infection

NCT ID: NCT00670839

An Observational Study of People Who Have Recently Been Infected With HIV

Condition: HIV Infections

NCT ID: NCT00103961

Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.

Condition: HIV Integrase, HIV Protease.

NCT ID: NCT01258374

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

Condition: HIV Infections

NCT ID: NCT00000767

Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy

Condition: HIV Infection

NCT ID: NCT01295515

Effects of Anti-HIV Therapy on Red Blood Cells of HIV-Infected Mothers and Their Infants

Condition: Cord Blood

NCT ID: NCT00342082

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Condition: Hepatitis; HIV/AIDS

NCT ID: NCT01443923

Pharmacogenetics of Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00435656

GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance

Condition: HIV-1 Infected Patients; Fold-change Resistance; Resistance Mutations

NCT ID: NCT01381328

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Condition: HIV-1 Infection

NCT ID: NCT01772940

A Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers

Condition: HIV

NCT ID: NCT00367458

Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda

Condition: HIV

NCT ID: NCT00342160

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Condition: HIV Infection

NCT ID: NCT00026676

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Condition: HIV Infections

NCT ID: NCT00000721

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons

Condition: HIV Infections; Coronary Artery Disease; Non-Alcoholic Fatty Liver Disease

NCT ID: NCT00889577

Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults

Condition: Cardiovascular Disease; HIV Infections

NCT ID: NCT00776412

Interleukin-2 With and Without Antiretroviral Therapy to Treat HIV-1 Infection

Condition: HIV Infections; HIV

NCT ID: NCT00106730

A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus

Condition: HIV Infections

NCT ID: NCT00000683

Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment

Condition: HIV Infections; HIV

NCT ID: NCT00105417

Immune Response to Influenza Vaccine in HIV-Infected Individuals

Condition: HIV Infections

NCT ID: NCT00069914

The Pharmacology/Aging Clinic

Condition: HIV Infection

NCT ID: NCT01286623

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

Condition: HIV Infection

NCT ID: NCT00025922

Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring

Condition: Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00836212

Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00286767

HLA-B35 Alleles and AIDS

Condition: HIV-1; AIDS

NCT ID: NCT00340223

Interleukin-2 Therapy for HIV Infection - Supplemental Procedures

Condition: Acquired Immunodeficiency Syndrome; HIV Infection

NCT ID: NCT00001354

PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen

Condition: HIV Infection

NCT ID: NCT01190293

Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients

Condition: HIV Infection; Immunologic Deficiency Syndrome

NCT ID: NCT00001651

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Condition: HIV

NCT ID: NCT01543152

Tissue Biopsy and Imaging Studies in HIV-Infected Patients

Condition: HIV Infection

NCT ID: NCT00001471

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00032669

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Condition: HIV Seronegativity; AIDS Vaccines

NCT ID: NCT00047931

Strategic Timing of Antiretroviral Treatment

Condition: HIV Infection

NCT ID: NCT00867048

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Condition: HIV-1

NCT ID: NCT01192035

Rifampin and Nevirapine Interactions in Young Children

Condition: Tuberculosis; HIV

NCT ID: NCT01699633

Rifampin and Efavirenz Interactions in Older Children

Condition: HIV; Tuberculosis

NCT ID: NCT01704144

Atazanavir Twice Daily

Condition: HIV Infections; Protease Inhibitor

NCT ID: NCT00357721

Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts

Condition: CD4 Lymphocytopenia; Idiopathic CD4 Positive T Lymphocytopenia

NCT ID: NCT00001319

Men Who Have Sex With Men (MSM) Neurocog 1&2 Study

Condition: HIV Related Neurocognitive Impairment

NCT ID: NCT01508559

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

Condition: Cryptococcosis

NCT ID: NCT00001701

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection

Condition: Blastomycosis

NCT ID: NCT00001702

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Condition: Cervical Cancer; Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT00667563

Single DermaVir Immunization in HIV-1 Infected Patients on HAART

Condition: HIV Infection

NCT ID: NCT00712530

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Condition: HIV Infection

NCT ID: NCT00711230

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)

Condition: HIV Infection

NCT ID: NCT00918840

Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

Condition: Lymphoma; Nonneoplastic Condition

NCT ID: NCT01319526

Raltegravir and Ezetimibe PK Study

Condition: HIV

NCT ID: NCT00772551

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00002427

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Condition: Kaposi's Sarcoma

NCT ID: NCT00686842

Lenalidomide in Kaposi Disease Associated With HIV Infection

Condition: HIV Infection Associated Kaposi Disease

NCT ID: NCT01282047

Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-Infected Patients Receiving Single-Dose Prednisone

Condition: Healthy

NCT ID: NCT00072644

GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women

Condition: Genital Herpes

NCT ID: NCT00808405

Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria

Condition: Secondary Pulmonary Arterial Hypertension; Sickle Cell Disease; Pulmonary Hypertension

NCT ID: NCT00367523

Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men

Condition: Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT00919997

Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus

Condition: Anal Cancer; Precancerous Condition

NCT ID: NCT00550589

CMV Disease and IRIS in HIV-1 Infected Persons

Condition: HIV Infections; Cytomegalovirus

NCT ID: NCT00456664

Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV

Condition: HIV

NCT ID: NCT00295477

Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection

Condition: HIV Infections; Staphylococcal Infections

NCT ID: NCT00859677

Suspended

Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility

Condition: Candidiasis; HIV Infections

NCT ID: NCT00692783

A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)

Condition: HIV Infections

NCT ID: NCT00000742

A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial

Condition: HIV Infections

NCT ID: NCT00622232

Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts

Condition: HIV Infections; Protozoan Infections

NCT ID: NCT00630162

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Condition: HIV Infections; Hemophilia A

NCT ID: NCT00002386

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

Condition: HIV Infections

NCT ID: NCT00001104

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

Condition: Aids-related Malignancies; Lymphoma; Precancerous Condition; Sarcoma

NCT ID: NCT00695422

Fanconi Syndrome Due to ARVs in HIV-Infected Persons

Condition: HIV Infections; Fanconi Syndrome; Kidney Disease; Renal Impairment

NCT ID: NCT00499187

Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

Condition: HIV Infection; Hemophilia A

NCT ID: NCT00797381

Not yet recruiting

The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis

Condition: CMV Disease

NCT ID: NCT00341172

Prospective Study of HIV Infection in Hemophiliacs

Condition: Acquired Immunodeficiency Syndrome; HIV Infections; Blood Disease; Hemophilia A; Hepatitis, Viral, Human; Blood Transfusion; Cytomegalovirus Infections

NCT ID: NCT00005309

Treatment of Hepatitis C in Hemophilic Patients With HIV

Condition: HIV Infections; Hepatitis C; Hemophilia

NCT ID: NCT00055341

Therapy to Elevate CD4 Counts in HIV-1 Disease

Condition: HIV Disease

NCT ID: NCT01370018

Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia

Condition: HIV Infections; Hemophilia A

NCT ID: NCT00000705

The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia

Condition: HIV Infections; Hemophilia A

NCT ID: NCT00002276

HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response

Condition: Risk Reduction Behavior; Sexual Behavior; Health Behavior; Drinking Behavior; Adolescent Behavior

NCT ID: NCT01169922

Collecting and Storing Blood Samples From Patients With Cancer

Condition: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Nonmalignant Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific

NCT ID: NCT00900120

Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments

Condition: HIV Infections; Central Nervous System Neoplasms; Neurofibromatosis 1

NCT ID: NCT01445314

Effects of Growth Hormone in Chronically Ill Children

Condition: - Hurler Syndrome (MPS-1) With Short Stature and Muscle Wasting; - Cerebral Palsy With Muscle Wasting; - Juvenile Rheumatoid Arthritis With Muscle Wasting and Short Stature; - Crohn’s Disease; - HIV Infection.

NCT ID: NCT00286689